170 related articles for article (PubMed ID: 29458303)
1. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.
De Smedt D; De Sutter J; De Pauw M; Vandekerckhove H; Trouerbach J; De Backer G; Willems AM; Pardaens S; Vervaet P; Deweerdt N; De Bacquer D
Acta Cardiol; 2019 Feb; 74(1):21-27. PubMed ID: 29458303
[TBL] [Abstract][Full Text] [Related]
2. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
[TBL] [Abstract][Full Text] [Related]
3. Educational level and risk profile and risk control in patients with coronary heart disease.
Bruthans J; Mayer O; De Bacquer D; De Smedt D; Reiner Z; Kotseva K; Cífková R;
Eur J Prev Cardiol; 2016 May; 23(8):881-90. PubMed ID: 26283652
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys.
De Backer G; De Bacquer D; Rydén L; Kotseva K; Gaita D; Georgiev B; Gotcheva N; Mancas S; Miličić D; Pająk A; Reiner Ž; Wood D;
Eur J Prev Cardiol; 2016 Oct; 23(15):1618-27. PubMed ID: 27084894
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
[TBL] [Abstract][Full Text] [Related]
6. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
7. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.
Kotseva K; Wood D; De Bacquer D;
Eur J Prev Cardiol; 2018 Aug; 25(12):1242-1251. PubMed ID: 29873511
[TBL] [Abstract][Full Text] [Related]
8. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
9. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P; De Sutter J; De Pauw M; Vandekerckhove H; De Backer G; Vervaet P; Deweerdt N; Dendale P; Persu A; Janssen A; Chenu P; Kotseva K; Gevaert S; De Bacquer D; De Smedt D; ;
Acta Cardiol; 2023 Jul; 78(5):607-613. PubMed ID: 36779380
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
[TBL] [Abstract][Full Text] [Related]
12. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
[TBL] [Abstract][Full Text] [Related]
13. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
14. The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology.
De Smedt D; Clays E; Höfer S; Oldridge N; Kotseva K; Maggioni AP; Pogosova N; Dolzhenko M; De Bacquer D
Eur J Prev Cardiol; 2016 Jul; 23(11):1174-86. PubMed ID: 26862122
[TBL] [Abstract][Full Text] [Related]
15. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU
Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
17. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.
Wagner M; Wanner C; Kotseva K; Wood D; De Bacquer D; Rydén L; Störk S; Heuschmann PU;
Eur J Prev Cardiol; 2017 Jul; 24(11):1168-1180. PubMed ID: 28503987
[TBL] [Abstract][Full Text] [Related]
19. The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.
De Smedt D; De Bacquer D; De Sutter J; Dallongeville J; Gevaert S; De Backer G; Bruthans J; Kotseva K; Reiner Ž; Tokgözoğlu L; Clays E
Int J Cardiol; 2016 Apr; 209():284-90. PubMed ID: 26913370
[TBL] [Abstract][Full Text] [Related]
20. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
